Matches in Wikidata for { <http://www.wikidata.org/entity/Q77223583> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q77223583 description "article scientifique publié en 1998" @default.
- Q77223583 description "artículu científicu espublizáu en setiembre de 1998" @default.
- Q77223583 description "im September 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q77223583 description "scientific article published on 01 September 1998" @default.
- Q77223583 description "wetenschappelijk artikel" @default.
- Q77223583 description "наукова стаття, опублікована у вересні 1998" @default.
- Q77223583 name "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 name "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 type Item @default.
- Q77223583 label "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 label "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 prefLabel "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 prefLabel "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 P1433 Q77223583-200B5486-EAE8-4594-ACF2-E79295D755A3 @default.
- Q77223583 P1476 Q77223583-820FE07C-FBA7-42D6-83D9-1724C7F12629 @default.
- Q77223583 P2860 Q77223583-0CB24B34-8D5B-4E4C-9CDF-564D2B671CEE @default.
- Q77223583 P2860 Q77223583-44A14570-A016-4FF5-A79F-FD5C7E40B382 @default.
- Q77223583 P2860 Q77223583-46E93FEC-1CE0-4737-91BE-BBE55E6A8C8F @default.
- Q77223583 P2860 Q77223583-6143CA2D-B719-4A55-9D63-06E602E8ACCF @default.
- Q77223583 P2860 Q77223583-69A720EA-33FD-4801-AEC4-532ACE125062 @default.
- Q77223583 P2860 Q77223583-6E0D9803-085E-4366-B99D-A81FFEA9E753 @default.
- Q77223583 P2860 Q77223583-73B64C72-DA80-41C5-8E9A-0676F03478D6 @default.
- Q77223583 P2860 Q77223583-78542A53-80CD-4BB7-82A0-548FE3AA07A5 @default.
- Q77223583 P2860 Q77223583-89AB38D7-830B-4F3F-902B-454C4A7E0A5A @default.
- Q77223583 P2860 Q77223583-9AD5F8B8-D941-49A8-B954-DCFD7DA57A8E @default.
- Q77223583 P2860 Q77223583-BA3167A9-B40B-4510-9785-7400033B1B66 @default.
- Q77223583 P2860 Q77223583-BDA856EA-15A4-4FC4-9A34-A0B4024E9EA0 @default.
- Q77223583 P2860 Q77223583-C2622765-6EAD-4A79-B2FA-D37872C500CB @default.
- Q77223583 P2860 Q77223583-CE48EC71-F0F7-4D5A-B1EC-4A4849E14C27 @default.
- Q77223583 P2860 Q77223583-D3477B30-C89C-4619-9A4C-AE0D0C203C02 @default.
- Q77223583 P2860 Q77223583-DFA24318-4468-4B58-B122-DF16E8A506E3 @default.
- Q77223583 P2860 Q77223583-E58B1416-BB4E-47B1-9798-2E4153EE4866 @default.
- Q77223583 P304 Q77223583-AE8B12A0-A097-472F-80F9-B7949ED0E30E @default.
- Q77223583 P31 Q77223583-DF621438-61FE-473F-96C5-97EA6BE23237 @default.
- Q77223583 P407 Q77223583-10DA8D65-DDFB-45D7-875A-D6E30A725975 @default.
- Q77223583 P433 Q77223583-A7FCC113-CC49-416C-8721-C133FF02FA00 @default.
- Q77223583 P478 Q77223583-4764D607-2B95-4EFB-A89B-C1CC033C5811 @default.
- Q77223583 P577 Q77223583-AA1B82FC-7575-4193-A864-6F1C24998F3F @default.
- Q77223583 P698 Q77223583-E0C3975E-27E0-4DE1-8AE7-2C3D61201881 @default.
- Q77223583 P921 Q77223583-3B102A0F-F0C5-4BE3-B353-E1BBC6BDF8AD @default.
- Q77223583 P921 Q77223583-7525F361-B082-4A7E-B12A-8B6C1113744A @default.
- Q77223583 P932 Q77223583-1F9E8580-41D2-4D4E-BA4C-AC864F064A57 @default.
- Q77223583 P698 9732339 @default.
- Q77223583 P1433 Q546003 @default.
- Q77223583 P1476 "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group" @default.
- Q77223583 P2860 Q28328155 @default.
- Q77223583 P2860 Q29617736 @default.
- Q77223583 P2860 Q33584707 @default.
- Q77223583 P2860 Q36598609 @default.
- Q77223583 P2860 Q44719697 @default.
- Q77223583 P2860 Q50547798 @default.
- Q77223583 P2860 Q50957725 @default.
- Q77223583 P2860 Q50977443 @default.
- Q77223583 P2860 Q52302060 @default.
- Q77223583 P2860 Q52889717 @default.
- Q77223583 P2860 Q53647051 @default.
- Q77223583 P2860 Q53652018 @default.
- Q77223583 P2860 Q53658625 @default.
- Q77223583 P2860 Q58678954 @default.
- Q77223583 P2860 Q68408466 @default.
- Q77223583 P2860 Q70300153 @default.
- Q77223583 P2860 Q71728018 @default.
- Q77223583 P304 "720-726" @default.
- Q77223583 P31 Q13442814 @default.
- Q77223583 P407 Q1860 @default.
- Q77223583 P433 "7160" @default.
- Q77223583 P478 "317" @default.
- Q77223583 P577 "1998-09-01T00:00:00Z" @default.
- Q77223583 P698 "9732339" @default.
- Q77223583 P921 Q1754768 @default.
- Q77223583 P921 Q3025883 @default.
- Q77223583 P932 "28661" @default.